MYOKARDIA INC's ticker is MYOK and the CUSIP is 62857M105. A total of 128 filers reported holding MYOKARDIA INC in Q3 2018. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,972,559 | +35.5% | 14,469 | -3.9% | 0.03% | +30.8% |
| Q2 2020 | $1,455,290 | +129.0% | 15,062 | +11.1% | 0.03% | +100.0% |
| Q1 2020 | $635,599 | -38.9% | 13,558 | -5.0% | 0.01% | -23.5% |
| Q4 2019 | $1,040,142 | +37.3% | 14,271 | -1.7% | 0.02% | +30.8% |
| Q3 2019 | $757,479 | +28.7% | 14,525 | +23.7% | 0.01% | +30.0% |
| Q2 2019 | $588,643 | +3.3% | 11,740 | +7.2% | 0.01% | 0.0% |
| Q1 2019 | $569,602 | +3.5% | 10,956 | -2.7% | 0.01% | -9.1% |
| Q4 2018 | $550,261 | -23.1% | 11,262 | +2.6% | 0.01% | -15.4% |
| Q3 2018 | $715,635 | -99.9% | 10,976 | +9.2% | 0.01% | +62.5% |
| Q2 2018 | $498,983,000 | +55.3% | 10,050 | +52.6% | 0.01% | +60.0% |
| Q1 2018 | $321,300,000 | +115892.8% | 6,584 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $277,000 | -51.1% | 6,584 | -50.2% | 0.00% | 0.0% |
| Q3 2017 | $567,000 | +227.7% | 13,227 | 0.0% | 0.00% | +300.0% |
| Q2 2017 | $173,000 | +8.8% | 13,227 | +36.0% | 0.00% | 0.0% |
| Q3 2016 | $159,000 | – | 9,724 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 399,360 | $54,445,000 | 40.54% |
| Copernicus Capital Management, LLC | 42,186 | $5,751,000 | 5.48% |
| Casdin Capital, LLC | 870,000 | $118,607,000 | 5.31% |
| Foresite Capital Management IV, LLC | 126,492 | $17,245,000 | 3.89% |
| Avoro Capital Advisors LLC | 1,885,000 | $256,982,000 | 3.65% |
| RTW INVESTMENTS, LP | 936,931 | $127,732,000 | 3.08% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 65,859 | $8,979,000 | 2.90% |
| Perceptive Advisors | 1,395,017 | $190,183,000 | 2.78% |
| Fernwood Investment Management, LLC | 38,547 | $5,255,000 | 2.48% |
| Grace Capital | 23,400 | $3,190,000 | 2.47% |